Rocket Lab stock fell today — here’s what RKLB traders are watching next
14 January 2026
1 min read

Rocket Lab stock fell today — here’s what RKLB traders are watching next

New York, Jan 13, 2026, 19:10 EST — After-hours

  • Rocket Lab shares dropped 1.5% Tuesday but edged up in after-hours trading.
  • The stock remains close to recent highs following a sharp surge linked to U.S. defense satellite contracts.
  • The company is set to release its next earnings report in late February.

Shares of Rocket Lab Corp ended Tuesday down 1.5%, closing at $86.58 after fluctuating between $89.73 and $85.65 during the day. In after-hours trading, the stock inched up 0.16% to $86.72. The regular session saw roughly 21.6 million shares change hands. 1

Rocket Lab (RKLB) remains close to the upper end of its recent trading range. Over the past year, the stock has surged roughly 260%, swinging between about $14.71 and $89.87, according to data from 6 .

The reason this matters now is clear: Rocket Lab has become a momentum player in the public space sector, and expectations are climbing. Investors demand evidence the company can convert defense contracts and its expanding space-systems unit into reliable cash flow, not just bigger backlog numbers.

In December, the U.S. Space Development Agency announced Rocket Lab secured a deal worth up to $805 million to build 18 missile-warning, tracking, and defense satellites for its Tracking Layer Tranche 3 program. Alongside Rocket Lab, similar contracts went to teams led by Lockheed Martin, Northrop Grumman, and L3Harris, with total commitments hitting roughly $3.5 billion. Launches are slated for fiscal 2029. Acting director Gurpartap “GP” Sandhoo said the constellation “will significantly increase the coverage and accuracy” of missile warning and tracking. 2

The SDA contracts rely on Other Transaction Authority, or OTA—a Pentagon tool designed to speed up procurement beyond traditional methods. For Rocket Lab, this marks a broader pivot from its reputation centered on the Electron launch vehicle toward developing spacecraft and payloads for government clients.

Rocket Lab’s latest quarterly report showed solid gains, though the company remains unprofitable. A November filing revealed revenue climbed 48% to $155.1 million in Q3, with GAAP gross margin hitting 37%. Net loss shrank to $18.3 million, or 3 cents per share. CEO Peter Beck highlighted the figures as “record revenue of $155m at record GAAP gross margin of 37%.” The same update noted Rocket Lab expects its Neutron rocket to reach Launch Complex 3 in Q1 2026, with a first launch scheduled after qualification testing. 3

Still, the trade carries risks. Analysts followed by MarketBeat set an average 12-month price target at $61.25, significantly under Tuesday’s closing price, despite the site’s “Moderate Buy” consensus rating. 4

Execution risk looms large: government programs often slip, hardware deliveries can be delayed, and a launch failure would quickly dampen enthusiasm. The stock’s volatility works both for and against investors.

Rocket Lab will report earnings on Feb. 26, per Yahoo Finance data. Investors will be watching closely to see how the Neutron rocket’s timeline holds up and when defense satellite contracts begin to impact revenue and margins. 5

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Chevron stock edges higher after-hours as Venezuela crude shift puts CVX in focus
Previous Story

Chevron stock edges higher after-hours as Venezuela crude shift puts CVX in focus

UnitedHealth (UNH) stock slips as Senate report puts Medicare Advantage under the microscope
Next Story

UnitedHealth (UNH) stock slips as Senate report puts Medicare Advantage under the microscope

Go toTop